Open Accessibility Menu
Hide

Event Details

2019 Cardiology Update Symposium

2019 Cardiology Update Symposium

About This Event

  • Event Type:Event
  • Max Capacity:0
Details:

Brought to you by St. Joseph and St. Mary’s Medical Centers and Kansas City Cardiology

The 2019 Cardiology Update is a one-day symposium designed for physicians, nurses, advanced practice providers, and other health professionals in acute and ambulatory care settings.

Eight national and local experts will give talks on new treatment guidelines, procedures, and evidence-based practices in cardiovascular medicine.

Friday, April 26, 2019

Agenda
7:15 a.m.
Registration
7:55 a.m. Welcome and Introduction, David Blick, M.D., F.A.C.C.
8 a.m. Update on TAVR, Jeffrey Sparling, M.D, F.A.C.C., F.S.C.A.I.
8:50 a.m. Anticoagulation in Non-Valvular Atrial Fibrillation, Hiren Shah, M.D.
9:40 a.m. Break
9:55 a.m. Reversal of Oral Anticoagulation Therapy, Paul Dobesh, Pharm. D., F.C.C.P., B.C.P.S., B.C.C.P.
10:45 a.m.To Play or Not to Play- Athletes and Heart Disease, Anthony Magalski, M.D., F.A.C.C., F.A.H.A., F.A.S.E., F.H.F.S.A.
11:35 a.m. Lunch
12:15 p.m. Smoking Cessation in the Setting of Cardiovascular Disease, Edward Ellerbeck, M.D., M.P.H.
1:05 p.m.Cannabinoid Cardiovascular Concerns, Michael Barton, Pharm. D., B.C.P.S., B.C.G.P.
1:55 p.m. Break
2:10 p.m. Minimizing Cancer Treatment Related Cardiovascular Toxicities, Charles Porter, M.D.
3:00 p.m. Borderline Elevated Troponin- MI or Not? David Blick, M.D., F.A.C.C.
3:50 p.m. Evaluation and Adjournment

Educational Objectives

• Discuss the latest indications and success with Transcatheter Aortic Valve Replacement
• Review options available for patients requiring anticoagulation for non-valvular atrial fibrillation
• Explain Pharmacological Reversal Agents for Anticoagulated Patients
• Recognize the prevalence and potential causes of sudden cardiac death in young athletes
• Discuss the challenges surrounding pre-participation cardiac screening of athletes
• Understand how to address smoking cessation in the setting of CV disease with a particular emphasis on the efficacy and safety of cessation pharmacotherapy
• Identify strategies for making systematic improvements in the delivery of cessation treatment to patients with CV disease
• Discuss potential clinical concerns with cannabis use and cardiac effects
• Explain the treatment of Cardiovascular Disease in Patients with Cancer
• Discuss Elevated Troponin Levels and the Relationship to Acute MI

Contact Information:

Sandra Dorrell, 816-525-1600 ext. 231

Registration
  • Price: $80.00
  • Registration Instructions: Please click and download the above registration form or call 816-525-1600 ext. 231 for more information or register via phone.